Literature DB >> 3019458

AIDS virus antibody in polytransfused dialysis patients vaccinated against hepatitis B.

J Desmyter, M Reynders, P Goubau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3019458      PMCID： PMC1341309          DOI： 10.1136/bmj.293.6546.537

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  HTLV-III infection in kidney transplant recipients.

Authors:  J L'age-Stehr; A Schwarz; G Offermann; H Langmaack; I Bennhold; M Niedrig; M A Koch
Journal:  Lancet       Date:  1985-12-14       Impact factor: 79.321

2.  HTLV-III antibodies in patients with kidney transplants or on haemodialysis.

Authors:  H H Neumayer; K Wagner; S Kresse
Journal:  Lancet       Date:  1986-03-01       Impact factor: 79.321

3.  HLA DR4 antibodies cause positive HTLV-III antibody ELISA results.

Authors:  P Kühnl; S Seidl; G Holzberger
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

4.  Transmission of AIDS virus at renal transplantation.

Authors:  C A Prompt; M M Reis; F M Grillo; J Kopstein; E Kraemer; R C Manfro; M H Maia; J B Comiran
Journal:  Lancet       Date:  1985-09-21       Impact factor: 79.321

5.  Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Double-blind placebo-controlled trial.

Authors:  J Desmyter; J Colaert; G De Groote; M Reynders; E E Reerink-Brongers; P N Lelie; P J Dees; H W Reesink
Journal:  Lancet       Date:  1983-12-10       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.